Synthetic Peptide
EPM2A Synthetic Peptide, PEP-1478, from Invitrogen.
The Epilepsy, progressive myoclonus type 2A protein (EPM2A) is a dual-specificity phosphatase that associates with polyribosomes. Mutations in this gene have been associated with myoclonic epilepsy of Lafora. EPM2A interacts with a number of proteins known to be involved in glycogen metabolism and has been shown to have robust phosphatase activity against a phosphorylated complex carbohydrate, suggesting that EPM2A may be involved in the regulation of glycogen metabolism.
| Marque | Invitrogen |
|---|---|
| Réf. B-LABO | BL-RE-175537 |
| Réf. fabricant | 15235389 |
| Gene ID (Entrez) | 7957 |
| Espèces | Human |
| Méthode de purification | purified |
| Numéro d’adhésion | B3EWF7 |
| Nom usuel | Human EPM2A |
| Concentration | 200 μg/mL |
| Contenu et stockage | -20°C |
| Format | Liquid |
| Formule | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| À utiliser avec (application) | Blocking Assay, Control |
| Symbole de gène(s) | EPM2A |
| Lyophilisé | No |
| Conservateur | 0.02% sodium azide |
| Type de produit | Peptide |
| Quantité | 50 μg |
| État réglementaire | RUO - research use only |
| Tampon de stockage | PBS |
